105 related articles for article (PubMed ID: 22027769)
1. [Apoptosis and expression of Fas/FasL in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma].
Jia JJ; Wang ZN; Liu GX; Wang ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1693-6. PubMed ID: 22027769
[TBL] [Abstract][Full Text] [Related]
2. Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma.
Jia J; Wang Z; Li X; Wang Z; Wang X
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):223-7. PubMed ID: 22142817
[TBL] [Abstract][Full Text] [Related]
3. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
4. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma.
Lijun Z; Xin Z; Danhua S; Xiaoping L; Jianliu W; Huilan W; Lihui W
Int J Gynecol Cancer; 2012 Jun; 22(5):836-41. PubMed ID: 22617481
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.
Houston A; Waldron-Lynch FD; Bennett MW; Roche D; O'Sullivan GC; Shanahan F; O'Connell J
Int J Cancer; 2003 Nov; 107(2):209-14. PubMed ID: 12949796
[TBL] [Abstract][Full Text] [Related]
7. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
8. [Expression of Fas and Fas ligand in infiltrating lymphocytes in patients with oral lichen planus].
Lei L; Tan WX; Zhou XL; Zheng PE
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Apr; 45(4):219-22. PubMed ID: 20654197
[TBL] [Abstract][Full Text] [Related]
9. [Effect of different concentrations of dexamethasone on apoptosis and expression of Fas/FasL in human osteoarthritis chondrocytes].
Tu Y; Xue H; Xia Z; Cai M; Liu X; Ma T; Zhang C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):536-41. PubMed ID: 22702044
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of immune escape in renal cell carcinoma].
Zheng J; Sun X; Chen J; Jiang F; Li W; Xie S
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):24-6. PubMed ID: 11977630
[TBL] [Abstract][Full Text] [Related]
11. Fas-FasL expression and myocardial cell apoptosis in patients with viral myocarditis.
Huang TF; Wu XH; Wang X; Lu IJ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420936
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
[TBL] [Abstract][Full Text] [Related]
13. The expression of Fas/FasL and apoptosis in yak placentomes.
JiangFeng F; Jiu YS; Wen ZZ; Ben L
Anim Reprod Sci; 2011 Oct; 128(1-4):107-16. PubMed ID: 22014664
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: relationship with neuronal cell death and inflammatory mediators.
Grosjean MB; Lenzlinger PM; Stahel PF; Yatsiv I; Shohami E; Trentz O; Kossmann T; Morganti-Kossmann MC
Histol Histopathol; 2007 Mar; 22(3):235-50. PubMed ID: 17163398
[TBL] [Abstract][Full Text] [Related]
16. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.
Randhawa SR; Chahine BG; Lowery-Nordberg M; Cotelingam JD; Casillas AM
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):286-92. PubMed ID: 20408337
[TBL] [Abstract][Full Text] [Related]
17. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
[TBL] [Abstract][Full Text] [Related]
18. Association between up-regulation of Fas ligand expression and apoptosis of tumor-infiltrating lymphocytes in human breast cancer.
Cheng B
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):573-5. PubMed ID: 17219972
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of Fas and FasL pro-apoptotic proteins in basal cell and squamous cell carcinomas.
Wang XY; Zhang R; Lian S
Clin Exp Dermatol; 2011 Jan; 36(1):69-76. PubMed ID: 20497185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
